Inactive Instrument

INTRASENS Share Price Swiss Exchange

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- EUR - Intraday chart for INTRASENS

Financials

Sales 2022 3.79M 4.08M 326M Sales 2023 3.3M 3.55M 285M Capitalization 18.8M 20.21M 1.62B
Net income 2022 -3M -3.23M -258M Net income 2023 -3M -3.23M -258M EV / Sales 2022 2.85 x
Net Debt 2022 650K 699K 55.96M Net cash position 2023 3.06M 3.29M 264M EV / Sales 2023 4.76 x
P/E ratio 2022
-2.97 x
P/E ratio 2023
-5.16 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 44.57%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 42 11/02/18
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 28/02/22
Members of the board TitleAgeSince
Chairman 65 07/10/20
Director/Board Member 63 14/03/19
Chief Executive Officer 42 11/02/18
More insiders
Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,200 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.
More about the company